APO Research
Talk to an analyst

APO RESEARCH · REPORT

Soluble Guanylate Cyclase (sGC) Stimulators

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Soluble Guanylate Cyclase (sGC) Stimulators Market Outlook and Growth Opportunities 2026

29 December 2025197 pages

Choose your research edition.

Industry ResearchSoluble Guanylate Cyclase (sGC) Stimulators Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Soluble Guanylate Cyclase (sGC) Stimulators Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Soluble Guanylate Cyclase (sGC) Stimulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Soluble Guanylate Cyclase (sGC) Stimulators Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Soluble Guanylate Cyclase (sGC) Stimulators Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Soluble Guanylate Cyclase (sGC) Stimulators market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Soluble Guanylate Cyclase (sGC) Stimulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Soluble Guanylate Cyclase (sGC) Stimulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Soluble Guanylate Cyclase (sGC) Stimulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Soluble Guanylate Cyclase (sGC) Stimulators market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Soluble Guanylate Cyclase (sGC) Stimulators market include Cipla, Dr Reddy's Laboratories, MSN, Bayer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Soluble Guanylate Cyclase (sGC) Stimulators market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Soluble Guanylate Cyclase (sGC) Stimulators and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Soluble Guanylate Cyclase (sGC) Stimulators sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Soluble Guanylate Cyclase (sGC) Stimulators market size, projected growth trends, production technologies, key applications, and end-use industries.

Soluble Guanylate Cyclase (sGC) Stimulators Segment by Company

Cipla

Dr Reddy's Laboratories

MSN

Bayer

Merck

Soluble Guanylate Cyclase (sGC) Stimulators Segment by Type

Vericiguat

Riociguat

Soluble Guanylate Cyclase (sGC) Stimulators Segment by Application

Chronic Thromboembolic Pulmonary Hypertension

Chronic Heart Failure

Pulmonary Hypertension

Other

Soluble Guanylate Cyclase (sGC) Stimulators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Soluble Guanylate Cyclase (sGC) Stimulators status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Soluble Guanylate Cyclase (sGC) Stimulators market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Soluble Guanylate Cyclase (sGC) Stimulators significant trends, drivers, influence factors in global and regions.

6. To analyze Soluble Guanylate Cyclase (sGC) Stimulators competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soluble Guanylate Cyclase (sGC) Stimulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Soluble Guanylate Cyclase (sGC) Stimulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soluble Guanylate Cyclase (sGC) Stimulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Soluble Guanylate Cyclase (sGC) Stimulators market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Soluble Guanylate Cyclase (sGC) Stimulators industry.

Chapter 3: Detailed analysis of Soluble Guanylate Cyclase (sGC) Stimulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Soluble Guanylate Cyclase (sGC) Stimulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Soluble Guanylate Cyclase (sGC) Stimulators in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Soluble Guanylate Cyclase (sGC) Stimulators Industry Trends Table 2. Soluble Guanylate Cyclase (sGC) Stimulators Industry Drivers Table 3. Soluble Guanylate Cyclase (sGC) Stimulators Industry Opportunities and Challenges Table 4. Soluble Guanylate Cyclase (sGC) Stimulators Industry Restraints Table 5. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Share by Company (2021-2026) Table 7. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume Share by Company (2021-2026) Table 9. Global Soluble Guanylate Cyclase (sGC) Stimulators Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Soluble Guanylate Cyclase (sGC) Stimulators Company Ranking, (2024-2026) & (USD Million) Table 11. Global Soluble Guanylate Cyclase (sGC) Stimulators Key Company Manufacturing Base & Headquarters Table 12. Global Soluble Guanylate Cyclase (sGC) Stimulators Company, Product Type & Application Table 13. Global Soluble Guanylate Cyclase (sGC) Stimulators Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Soluble Guanylate Cyclase (sGC) Stimulators by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Vericiguat Table 18. Significant Companies of Riociguat Table 19. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume Share by Type (2021-2026) Table 23. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume Share by Type (2027-2032) Table 24. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type (2021-2026) Table 28. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Chronic Thromboembolic Pulmonary Hypertension Table 30. Significant Companies of Chronic Heart Failure Table 31. Significant Companies of Pulmonary Hypertension Table 32. Significant Companies of Other Table 33. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume Share by Application (2021-2026) Table 37. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume Share by Application (2027-2032) Table 38. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application (2021-2026) Table 42. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application (2027-2032) Table 43. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region (2021-2026) & (K Units) Table 45. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Region (2021-2026) Table 46. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region (2027-2032) & (K Units) Table 47. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Region (2027-2032) Table 48. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Region (2021-2026) Table 51. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Region (2027-2032) Table 53. Global Soluble Guanylate Cyclase (sGC) Stimulators Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Soluble Guanylate Cyclase (sGC) Stimulators Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2026) & (K Units) Table 58. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Country (2021-2026) Table 59. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2027-2032) & (K Units) Table 60. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Country (2027-2032) Table 61. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Market Share by Country (2021-2026) Table 63. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Market Share by Country (2027-2032) Table 65. Cipla Company Information Table 66. Cipla Business Overview Table 67. Cipla Soluble Guanylate Cyclase (sGC) Stimulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Cipla Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio Table 69. Cipla Recent Development Table 70. Dr Reddy's Laboratories Company Information Table 71. Dr Reddy's Laboratories Business Overview Table 72. Dr Reddy's Laboratories Soluble Guanylate Cyclase (sGC) Stimulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Dr Reddy's Laboratories Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio Table 74. Dr Reddy's Laboratories Recent Development Table 75. MSN Company Information Table 76. MSN Business Overview Table 77. MSN Soluble Guanylate Cyclase (sGC) Stimulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. MSN Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio Table 79. MSN Recent Development Table 80. Bayer Company Information Table 81. Bayer Business Overview Table 82. Bayer Soluble Guanylate Cyclase (sGC) Stimulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Bayer Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio Table 84. Bayer Recent Development Table 85. Merck Company Information Table 86. Merck Business Overview Table 87. Merck Soluble Guanylate Cyclase (sGC) Stimulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Merck Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio Table 89. Merck Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Soluble Guanylate Cyclase (sGC) Stimulators Distributors List Table 93. Soluble Guanylate Cyclase (sGC) Stimulators Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Soluble Guanylate Cyclase (sGC) Stimulators Product Image Figure 2. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value (2021-2032) & (US$ Million) Figure 4. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales (2021-2032) & (K Units) Figure 5. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Soluble Guanylate Cyclase (sGC) Stimulators Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Vericiguat Image Figure 10. Riociguat Image Figure 11. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume Share by Type (2021-2032) Figure 14. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type (2021-2032) Figure 17. Chronic Thromboembolic Pulmonary Hypertension Image Figure 18. Chronic Heart Failure Image Figure 19. Pulmonary Hypertension Image Figure 20. Other Image Figure 21. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume Share by Application (2021-2032) Figure 24. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application (2021-2032) Figure 27. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Soluble Guanylate Cyclase (sGC) Stimulators Sales Value (2021-2032) & (US$ Million) Figure 32. North America Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Soluble Guanylate Cyclase (sGC) Stimulators Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Soluble Guanylate Cyclase (sGC) Stimulators Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Soluble Guanylate Cyclase (sGC) Stimulators Sales Value (2021-2032) & (US$ Million) Figure 38. South America Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Soluble Guanylate Cyclase (sGC) Stimulators Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Soluble Guanylate Cyclase (sGC) Stimulators Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Vericiguat
  • Riociguat
Applications
  • Chronic Thromboembolic Pulmonary Hypertension
  • Chronic Heart Failure
  • Pulmonary Hypertension
  • Other
Companies covered
  • Cipla
  • Dr Reddy's Laboratories
  • MSN
  • Bayer
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value (2021-2032)
  4. 1.2.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume (2021-2032)
  5. 1.2.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Soluble Guanylate Cyclase (sGC) Stimulators Market Dynamics
  1. 2.1 Soluble Guanylate Cyclase (sGC) Stimulators Industry Trends
  2. 2.2 Soluble Guanylate Cyclase (sGC) Stimulators Industry Drivers
  3. 2.3 Soluble Guanylate Cyclase (sGC) Stimulators Industry Opportunities and Challenges
  4. 2.4 Soluble Guanylate Cyclase (sGC) Stimulators Industry Restraints
3 Soluble Guanylate Cyclase (sGC) Stimulators Market by Company
  1. 3.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Company Revenue Ranking in 2025
  2. 3.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Company (2021-2026)
  3. 3.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Company (2021-2026)
  4. 3.4 Global Soluble Guanylate Cyclase (sGC) Stimulators Average Price by Company (2021-2026)
  5. 3.5 Global Soluble Guanylate Cyclase (sGC) Stimulators Company Ranking (2024-2026)
  6. 3.6 Global Soluble Guanylate Cyclase (sGC) Stimulators Company Manufacturing Base and Headquarters
  7. 3.7 Global Soluble Guanylate Cyclase (sGC) Stimulators Company Product Type and Application
  8. 3.8 Global Soluble Guanylate Cyclase (sGC) Stimulators Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Soluble Guanylate Cyclase (sGC) Stimulators Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Soluble Guanylate Cyclase (sGC) Stimulators Market by Type
  1. 4.1 Soluble Guanylate Cyclase (sGC) Stimulators Type Introduction
  2. 4.1.1 Vericiguat
  3. 4.1.2 Riociguat
  4. 4.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Type
  5. 4.2.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Type
  9. 4.3.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Type (2021-2032)
  11. 4.3.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type (2021-2032)
5 Soluble Guanylate Cyclase (sGC) Stimulators Market by Application
  1. 5.1 Soluble Guanylate Cyclase (sGC) Stimulators Application Introduction
  2. 5.1.1 Chronic Thromboembolic Pulmonary Hypertension
  3. 5.1.2 Chronic Heart Failure
  4. 5.1.3 Pulmonary Hypertension
  5. 5.1.4 Other
  6. 5.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Application
  7. 5.2.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Application
  11. 5.3.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Application (2021-2032)
  13. 5.3.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application (2021-2032)
6 Soluble Guanylate Cyclase (sGC) Stimulators Regional Sales and Value Analysis
  1. 6.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region (2021-2032)
  3. 6.2.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region: 2021-2026
  4. 6.2.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region (2027-2032)
  5. 6.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Region (2021-2032)
  7. 6.4.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Region: 2021-2026
  8. 6.4.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Region (2027-2032)
  9. 6.5 Global Soluble Guanylate Cyclase (sGC) Stimulators Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Soluble Guanylate Cyclase (sGC) Stimulators Sales Value (2021-2032)
  12. 6.6.2 North America Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Soluble Guanylate Cyclase (sGC) Stimulators Sales Value (2021-2032)
  15. 6.7.2 Europe Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Soluble Guanylate Cyclase (sGC) Stimulators Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Soluble Guanylate Cyclase (sGC) Stimulators Sales Value (2021-2032)
  21. 6.9.2 South America Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Country, 2025 VS 2032
7 Soluble Guanylate Cyclase (sGC) Stimulators Country-level Sales and Value Analysis
  1. 7.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2032)
  4. 7.3.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2026)
  5. 7.3.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2027-2032)
  6. 7.4 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Country (2021-2032)
  7. 7.4.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Country (2021-2026)
  8. 7.4.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Soluble Guanylate Cyclase (sGC) Stimulators Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cipla
  2. 8.1.1 Cipla Company Information
  3. 8.1.2 Cipla Business Overview
  4. 8.1.3 Cipla Soluble Guanylate Cyclase (sGC) Stimulators Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cipla Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
  6. 8.1.5 Cipla Recent Developments
  7. 8.2 Dr Reddy's Laboratories
  8. 8.2.1 Dr Reddy's Laboratories Company Information
  9. 8.2.2 Dr Reddy's Laboratories Business Overview
  10. 8.2.3 Dr Reddy's Laboratories Soluble Guanylate Cyclase (sGC) Stimulators Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Dr Reddy's Laboratories Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
  12. 8.2.5 Dr Reddy's Laboratories Recent Developments
  13. 8.3 MSN
  14. 8.3.1 MSN Company Information
  15. 8.3.2 MSN Business Overview
  16. 8.3.3 MSN Soluble Guanylate Cyclase (sGC) Stimulators Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 MSN Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
  18. 8.3.5 MSN Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Soluble Guanylate Cyclase (sGC) Stimulators Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Soluble Guanylate Cyclase (sGC) Stimulators Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merck Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
  30. 8.5.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Soluble Guanylate Cyclase (sGC) Stimulators Value Chain Analysis
  2. 9.1.1 Soluble Guanylate Cyclase (sGC) Stimulators Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Soluble Guanylate Cyclase (sGC) Stimulators Sales Mode & Process
  6. 9.2 Soluble Guanylate Cyclase (sGC) Stimulators Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Soluble Guanylate Cyclase (sGC) Stimulators Distributors
  9. 9.2.3 Soluble Guanylate Cyclase (sGC) Stimulators Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst